MPV17L

Chr 16

MPV17 mitochondrial inner membrane protein like

Also known as: M-LPH, M-LPH1, M-LPH2, MLPH1, MLPH2, MPV17L1

The MPV17L protein regulates reactive oxygen species metabolism in peroxisomes and protects against mitochondrial apoptotic pathways by modulating antioxidant enzyme expression. Mutations cause autosomal recessive neurodegeneration with brain iron accumulation. The gene is not highly constrained against loss-of-function variants, consistent with recessive inheritance.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.77
Clinical SummaryMPV17L
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
188 unique Pathogenic / Likely Pathogenic· 174 VUS of 385 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.77LOEUF
pLI 0.000
Z-score -0.22
OE 1.08 (0.651.77)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.45Z-score
OE missense 0.87 (0.731.05)
84 obs / 96.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE1.08 (0.651.77)
00.351.4
Missense OE0.87 (0.731.05)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 9 / 8.3Missense obs/exp: 84 / 96.3Syn Z: 0.36
DN
0.76top 25%
GOF
0.6639th %ile
LOF
0.2872th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

385 submitted variants in ClinVar

Classification Summary

Pathogenic141
Likely Pathogenic47
VUS174
Likely Benign7
Benign1
141
Pathogenic
47
Likely Pathogenic
174
VUS
7
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
141
0
141
Likely Pathogenic
0
0
47
0
47
VUS
1
43
130
0
174
Likely Benign
0
5
1
1
7
Benign
0
0
1
0
1
Total1483201370

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MPV17L · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →